Clinical and genetic determinants of ovarian metastases from colorectal cancer.


BACKGROUND Ovarian metastases from colorectal cancer (OM-CRC) often are unresponsive to chemotherapy and are associated with poor survival. To the authors' knowledge, the clinicopathologic and genomic predictors of OM-CRC are poorly characterized and optimal clinical management remains unclear. METHODS Women with a histopathological diagnosis of OM-CRC… (More)
DOI: 10.1002/cncr.30424


Cite this paper

@article{Ganesh2017ClinicalAG, title={Clinical and genetic determinants of ovarian metastases from colorectal cancer.}, author={K. Venkata Ganesh and Ronak H Shah and Efsevia Vakiani and Garrett M. Nash and Hugh P Skottowe and Rona D Yaeger and Andrea Cercek and Anne E. Lincoln and Christina P. Tran and Neil Howard Segal and Diane Lauren Reidy and Anna Varghese and Andrew S. Epstein and Yukio Sonoda and Dennis Chi and Jos{\'e} Guillem and Larissa K. F. Temple and Philip S k Paty and Jaclyn Frances Hechtman and Jinru Shia and Martin Weiser and Julio Garcia Aguilar and Nancy E. Kemeny and Michael F. Berger and Leonard B. Saltz and Zsofia Kinga Stadler}, journal={Cancer}, year={2017}, volume={123 7}, pages={1134-1143} }